Work

Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.7002

Authors: Noelle V. Frey, Pamela A Shaw, Elizabeth O. Hexner, Saar Gill, Katherine Marcucci, Selina M. Luger, James K. Mangan, Stephan A. Grupp, Shannon L. Maude, Solveig Ericson, Bruce Levine, Simon F. Lacey, Jan J. Melenhorst, Carl H. June, David L. Porter

Institutions: Abramson Cancer Center, University of Pennsylvania, Children's Hospital of Philadelphia, Novartis (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2500019491

Cites:

Cited by: 42

Related to: 10